Genentech (NYSE:DNA) formerly known as (NYSE:GNE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genentech (NYSE:DNA) formerly known as (NYSE:GNE)

DNA 8.400

-5.7%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (119)	1/5/2007 11:48:14 AM
From: tuck	Read Replies (1) of 250

Thanks, a good review of "pharmaspeak." DNA was to make a "go/no go" decision on Omnitarg based on this data. It'll be interesting to see if they go or not. Depends, I suppose, on by how wide a margin they missed the endpoint. I'm expecting more clues on this at ASCO, though whether or not that predates their decision remains to be seen . . . Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next